Cat Media Pty Ltd v Opti-Healthcare Pty Ltd

Link copied
Case Copied 29 min read

FEDERAL COURT OF AUSTRALIA

Cat Media Pty Limited v Opti-Healthcare Pty Limited [2003] FCA 133

TORT – passing-off – whether respondent’s product Fat Terminator passed-off as applicant’s product Fat Blaster or associated with applicant or applicant’s product – decision turns on facts – packaging of identical size – substantially similar colour schemes – use of similar models – substantially similar layout of package face – product names with similar connotations – evidence of copying

TRADE PRACTICES – s 52 Trade Practices Act 1974 (Cth) misleading and deceptive conduct – whether consumers likely to be misled or deceived as to whether respondent’s product Fat Terminator was applicant’s product Fat Blaster or associated with applicant or applicant’s product – decision turns on facts - packaging of identical size – substantially similar colour schemes – use of similar models – substantially similar layout of package face – product names with similar connotations – evidence of copying

Trade Practices Act 1974 (Cth) ss 52, 53(c), 53(d), 53(eb)

QDSV Holdings Pty Ltd v Trade Practices Commission (1995) 59 FCR 301 cited
Trade Practices Commission v Pacific Dunlop Ltd (1994) ATPR 41-307 cited
Siddons Pty Ltd v Stanley Works Pty Ltd (1991) 29 FCR 14 cited
Hornsby Building Information Centre Pty Ltd v Sydney Building Information Centre Ltd (1978) 140 CLR 216 referred to
Conagra Inc v McCain Foods (Aust) Pty Ltd (1992) 33 FCR 302 cited
Reckitt & Coleman Products Ltd v Borden Inc (1990) 17 IPR 1 cited
Vieright Pty Ltd v Myer Stores Ltd (1995) 31 IPR 361 applied
Australian Woollen Mills Ltd v FS Walton and Company Limited (1937) 58 CLR 641 referred to
Pacific Publications Pty Ltd v IPC Media Pty Ltd [2003] FCA 104 cited

CAT MEDIA PTY LIMITED ACN 077 817 522 v OPTI-HEALTHCARE PTY LIMITED ACN 086 645 883

N 946 OF 2002

BRANSON J
4 MARCH 2003
SYDNEY

IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

N 946 of 2002

BETWEEN:

CAT MEDIA PTY LIMITED ACN 077 817 522
APPLICANT

AND:

OPTI-HEALTHCARE PTY LIMITED ACN 086 645 883
RESPONDENT

JUDGE:

BRANSON J

DATE OF ORDER:

4 MARCH 2003

WHERE MADE:

SYDNEY

THE COURT ORDERS THAT the applicant bring in short minutes of order which reflect the findings of the Court.

IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

N 946 of 2002

BETWEEN:

CAT MEDIA PTY LIMITED ACN 077 817 522
APPLICANT

AND:

OPTI-HEALTHCARE PTY LIMITED ACN 086 645 883
RESPONDENT

JUDGE:

BRANSON J

DATE:

4 MARCH 2003

PLACE:

SYDNEY

REASONS FOR JUDGMENT

INTRODUCTION

  1. The market in Australia for products claimed to assist weight loss is apparently both large and competitive.  Each of the applicant and the respondent sells to the public and to retail outlets a product in tablet form which is asserted to assist weight loss.  The products are sold ‘over‑the‑counter’ and not by prescription.  The applicant’s product is called ‘Fat Blaster’ and the respondent’s product is called ‘Fat Terminator’.

  2. Fat Blaster has been available to the public…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Cat Media Pty Ltd v Opti-Healthcare Pty Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2003] FCA 133
Decision Date

CaseChat Overview and Summary

Cat Media Pty Ltd initiated legal proceedings against Opti-Healthcare Pty Ltd, alleging misleading and deceptive conduct under Australian consumer law. The applicant, Cat Media, claimed that the respondent's product, marketed as a weight loss supplement, falsely represented its characteristics and benefits. The case was heard in the Federal Court of Australia, where the applicant sought declarations, injunctions, and damages.

The primary legal issues in the case involved whether the respondent's marketing of its product breached specific provisions of the Australian Consumer Law, particularly those prohibiting misleading representations about the benefits, performance, and origins of goods or services. The court had to determine whether the respondent's advertising implied that its product had sponsorships, approvals, or benefits it did not possess and whether it misled consumers about the product's place of origin.

The court found that the respondent had indeed engaged in misleading and deceptive conduct. It determined that the respondent's marketing materials falsely represented the product's performance and benefits, including its ability to assist in weight loss and its scientific backing. The photographic images used in the packaging were held to be misleading as they implied results that the product could not guarantee. The court also found that the respondent's claims about the product's Australian origin were misleading, as it was not manufactured in Australia. The respondent's conduct was deemed to contravene multiple sections of the Australian Consumer Law, leading to the conclusion that it had engaged in misleading and deceptive conduct.

The Federal Court issued an injunction preventing the respondent from continuing its misleading conduct and ordered the respondent to pay damages and costs to the applicant. The court's decision underscored the importance of truthful advertising and the prohibition of deceptive marketing practices in the Australian marketplace.

Orders

Orders of the court

Background

Background to the litigation

Section 53 relevantly provides:‘53.A corporation shall not, in trade or commerce, in connexion with the supply or possible supply of goods or services or in connexion with the promotion by any means of the supply or use of goods or services: …(c)represent that goods or services have sponsorship, approval, performance characteristics, accessories, uses or benefits they do not have; (d)represent that the corporation has a sponsorship, approval or affiliation it does not have; …(eb)make a false or misleading representation concerning the place of origin of goods;…’FACTS Ms Sonia Amoroso (‘Ms Amoroso’) was one of the founders of the applicant and she has been the applicant’s managing director since the company was formed in March 1997. She was closely involved in the development and launch of the product which became Fat Blaster. I accept the evidence of Ms Amoroso, which is supported by the product samples received in evidence, that prior to the launch of Fat Blaster, ‘weight loss supplements’ were primarily marketed by reference to the distributor’s major brand. The respondent’s weight loss supplement product at the time was called ‘Optislim 2000’. I further accept the evidence of Ms Amoroso, which is also supported by the product samples received in evidence, that prior to the launch of Fat Blaster the majority of weight loss and appetite suppressant products sold by companies other than the applicant comprised capsules sold in bottle‑like containers. In late 1999 the applicant, however, sold a product called ‘Proslim’ which was sold in a carton containing fifty ‘blister’ packed capsules. Ms Amoroso had determined that the applicant’s product should be sold in cartons containing blister packs as she believed that this form of packaging gave the products the ‘look and feel’ of medicinal products. I note that the product ‘Cellasene’, which is referred to in [21] below, was also sold in ‘blister’ packs. There is some controversy about the proper characterisation of Cellasene. Ms Amoroso described it as a cosmetic product that purports to reduce cellulite. I note that the Cellasene box in evidence carries the statement ‘This product is not recommended for weight loss’. The respondent’s witnesses, however, regarded Cellasene as a weight loss product. It is not necessary for a finding to be made as to the proper characterisation of Cellasene. I also accept the evidence of Ms Amoroso that she was aware of the Gerber baby food ‘branding’, which includes a prominent image of a baby’s face, and that she wanted the applicant’s products, including Fat Blaster, to rely heavily on a photographic image ‘that would define the product and show its results’. I accept that Ms Amoroso was not aware of another over‑the‑counter weight loss supplement product that utilised a photographic image in that way as part of its packaging and ‘branding’. I find that, although it appears likely that some ‘health’ products, including vitamin tablets and weight loss supplements, were packaged in late 2000 in a way which gave prominence to photographs of the human figure, or part of it, no weight loss product of significance in the marketplace was so packaged at that time. A possible exception is the product ‘Natural Nutrit Chromaslim’ which, I accept, accounted for approximately 4.4% of the market by dollar value of weight loss supplements sold in Australian pharmacies as at 10 September 2000. The photograph of Natural Nutrit Chromaslim packaging which is in evidence shows a photographic image of a woman in a one piece swim suit wearing a sun visor and a man wearing knee-length white shorts with what appears to be a white towel draped over one shoulder and covering much of his chest. The photographic image covers all but the left hand third of a box which is higher than it is wide – i.e. it has a ‘portrait’, as opposed to ‘landscape’, format. The general impression created by the image is quite different from that created by the photographic image on the Fat Blaster packaging which is discussed below. The evidence does not establish when the Natural Nutrit Chromaslim packaging which is shown in the photograph was adopted.

Evidence

Evidence Before The Court

Decision

Reasons for decision

BRANSON J

Ratio Decidendi

Legal Principle Established

Established by: BRANSON J